The quality of care of very low birth weight babies in Brazil

4. Must A, Jacques PF, Dallal GE, Bajema CJ, Dietz WH. Long-termmorbidity and mortality of overweight adolescents. A follow-upof the Harvard Growth Study of 1922 to 1935. N Engl J Med.1992;327:1350-5.5. Sinaiko AR, Donahue RP, Jacobs DR Jr., Prineas RJ. Relation ofrate of growth during childhood and adolescence to fastinginsulin, lipids, and systolic blood pressure in young adults.Circulation. 1999;99:1471-6.6. Ogden CL, Flegal KM, Carroll MD, Johnson CL. Prevalence andtrends in overweight among US children and adolescents,1999-2000. JAMA. 2002;288:1728-32.7. Sinaiko AR, Steinberger J, Moran A, Hong CP, Prineas RJ, JacobsDR Jr. Influence of insulin resistance and BMI at age 13 onsystolic blood pressure, triglycerides and HDL-C at age 19.Hypertension. 2006;48:730-6.8. Montague CT, O’Rahilly S. The perils of portliness: causes andconsequences of visceral adiposity. Diabetes. 2000;49:883-8.9. FerreiraAP,OliveiraCE,FrancaNM.Metabolicsyndromeandriskfactors for cardiovascular disease in obese children: therelationshipwithinsulinresistance(HOMA-IR).JPediatr(RioJ).2007;83:21-6.10. CookS,WeitzmanM,AuingerP,NguyenM,DietzWH.Prevalenceof a metabolic syndrome phenotype in adolescents: findingsfrom the third National Health and Nutrition ExaminationSurvey, 1988-1994. Arch Pediatr Adolesc Med.2003;157:821-7.11. Kahn R, Buse J, Ferrannini E, Stern M; American DiabetesAssociation; European Association for the Study of Diabetes.The metabolic syndrome: time for a critical appraisal: jointstatement from the American Diabetes Association and theEuropean Association for the Study of Diabetes. Diabetes Care.2005;28:2289-304.12. Ferrannini E, Mari A. How to measure insulin sensitivity.JHypertens. 1998;18:895-906.13. Balkau B, Charles MA. Comment on the provisional report fromthe WHO consultation. European Group for the Study of InsulinResistance (EGIR). Diabet Med. 1999;16:442-3.